Fertomid 25 (Clomiphene Citrate 25 mg)

Fertomid 25 contains 25 mg of Clomiphene Citrate, an orally active non-steroidal Selective Estrogen Receptor Modulator (SERM) and ovulatory stimulant manufactured by Cipla Ltd. It is specifically prescribed for women facing infertility due to ovulatory failure, irregular cycles (oligomenorrhea), or Polycystic Ovary Syndrome (PCOS). By temporarily blocking estrogen feedback at the hypothalamic level, Fertomid 25 prompts the body’s natural release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), triggering dominant follicle maturation and spontaneous ovulation.

Product Specifications

How Fertomid 25 Works in Women (Mechanism of Action)

In natural reproductive biology, ovulation relies on continuous hormonal cross-talk between the hypothalamus, the pituitary gland, and the ovaries (the HPO axis).

1. Estrogen Receptor Antagonism: Clomiphene binds competitively to nuclear estrogen receptors in the hypothalamus, temporarily preventing circulating estrogen from registering its presence.
2. Endogenous Gonadotropin Surge: Sensing an apparent drop in estrogen, the hypothalamus increases pulsatile secretion of Gonadotropin-Releasing Hormone (GnRH), directing the pituitary to release elevated levels of FSH and LH.
3. Follicular Recruitment & Ovulation: Elevated FSH stimulates the growth of resting ovarian follicles, allowing one or more dominant follicles to mature. As the mature follicle produces natural estradiol, it triggers a surge of LH that prompts the release of a fertile egg into the fallopian tube.

Primary Uses of Fertomid 25 in Female Infertility

1. Ovulation Induction in Polycystic Ovary Syndrome (PCOS)

PCOS is one of the most common causes of female Infertility, marked by multiple small, immature follicles that fail to mature and release an egg. Fertomid 25 provides the endocrine stimulus needed to overcome this arrest, facilitating dominant follicle selection and ovulatory release.

2. Why the 25 mg Dose is Clinically Prescribed

While standard protocols often begin at 50 mg, fertility specialists frequently utilize Fertomid 25 mg for:

• PCOS “Hyper-Responders”: Women with high anti-Müllerian hormone (AMH) or elevated baseline antral follicle counts who are at higher risk of developing multiple large follicles or ovarian hyperstimulation on higher doses.
• Minimizing Side Effects: Reducing peripheral anti-estrogenic side effects like hot flushes, mood changes, and cervical mucus drying.
• Step-Down Titration: Patients who ovulated with multiple large cysts on a 50 mg regimen and require a milder, more controlled stimulation.

3. Unexplained & Anovulatory Subfertility

For women with regular or irregular cycles who fail to conceive despite open fallopian tubes and normal semen parameters, Fertomid 25 is used to establish predictable mid-cycle egg release, simplifying the timing of natural intercourse or Intrauterine Insemination (IUI).

Step-by-Step Administration & Timed Intercourse Protocol

Fertomid 25 is taken in cyclic 5-day bursts rather than on a continuous daily schedule.

1. Cycle Confirmation (Day 1): The first day of bright red menstrual bleeding is counted as Day 1 of your cycle. (If you do not have periods, your gynaecologist may induce a withdrawal bleed using a short course of progestin).
2. Initiating the 5-Day Course: Under your physician’s guidance, begin taking Fertomid 25 once daily starting on Day 2, Day 3, or Day 5 of your menstrual cycle.
3. Daily Routine: Swallow each tablet whole with a glass of water, with or without food. Take it at roughly the same time every day (e.g., evening with dinner to sleep through potential mild hot flushes).
4. Predicting Ovulation: Ovulation typically occurs 5 to 10 days after taking the 5th and final tablet of the cycle (frequently between Cycle Days 12 and 18).
5. Timing Conception: To maximize pregnancy chances, schedule regular intercourse every other day beginning on Cycle Day 10 through Cycle Day 18, or track your surge using urinary LH test strips or follicular ultrasound tracking.
6. Maximum Cycle Limit: Clinical guidelines state that cyclic therapy should not exceed 3 to 6 ovulatory cycles. If pregnancy is not achieved after 3–6 confirmed ovulations, your doctor will re-evaluate for other fertility factors (such as tubal patency or endometrial receptivity).

Safety Profile, Potential Side Effects & Warnings

Because clomiphene alters estrogen signaling, patients may experience transient side effects. Most are mild and resolve after completing the 5-day course.

Common & Manageable Symptoms

• Vasomotor Hot Flushes (~10%): Sudden feeling of warmth across the face and upper chest, similar to menopausal symptoms, caused by hypothalamic estrogen blockade.
• Abdominal Bloating & Pelvic Discomfort (~5.5%): A sensation of pelvic fullness or mild aching as ovaries produce growing follicles.
• Breast Tenderness & Nausea (~2%): Temporary shifts in circulating estrogen and progesterone balance.
• Mood Swings & Headaches: Mild irritability, emotional sensitivity, or tension headaches.

Important Clinical Warnings

• Multiple Pregnancy Risk: While the rate of triplets or higher remains under 1%, the chance of a twin pregnancy increases to approximately 5% to 8% due to multiple follicles maturing simultaneously.
• Cervical Mucus Changes: Because clomiphene has anti-estrogenic properties, it can occasionally cause cervical mucus to become thicker or drier than usual. Fertility-friendly lubricants can help during intercourse.
• Visual Disturbances (Scintillating Scotomata): A small percentage of women (~1.5%) experience temporary blurred vision, light flashes, or sensitivity to bright light. If you experience any visual symptoms, stop taking the medication immediately and contact your doctor. Do not drive or operate machinery if vision is impaired.
• Ovarian Hyperstimulation Syndrome (OHSS): Severe pelvic swelling, rapid weight gain, shortness of breath, and intense nausea indicate hyperstimulation. Although less common at the lower 25 mg dose, seek immediate medical attention if these symptoms develop.

Contraindications: When Fertomid 25 Must NOT Be Used

Fertomid 25 is strictly contraindicated in women with:

1. Confirmed or Suspected Pregnancy (Category X): A reliable pregnancy test must be confirmed negative before starting every single 5-day course.
2. Undiagnosed Abnormal Vaginal Bleeding: Irregular, unexplained uterine bleeding must be fully investigated prior to initiating therapy.
3. Active Liver Disease or Hepatic Impairment: Clomiphene is metabolized by the liver; compromised hepatic function leads to drug accumulation and toxicity.
4. Ovarian Cysts Unrelated to PCOS: Women with pre-existing ovarian enlargement or cysts must avoid stimulation to prevent cyst rupture or ovarian torsion.
5. Hormone-Dependent Tumours: Active endometrial cancer, hormone-sensitive breast tumours, or other estrogen-dependent malignancies.